Phillips-Medisize creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices.
Plans
Phillips-Medisize is creating a manufacturing Center of Excellence for Connected Health and drug delivery devices, the company has announced.
The company will expand its Molex Little Rock facility in Arkansas by installing purpose built cleanrooms and acquiring FDA registration and ISO 13485 certification ready for its first customer’s production starting next year.
The construction of the facility is intended for Phillips-Medisize’s medical business and will have capabilities for filling, drug handling, electronics and connected devices. The investment aims to combine the solutions and knowledge of Molex’s electronics production with Phillips-Medisize’s platform of drug delivery and medical device expertise.
Matt Jennings, CEO and President of Phillips-Medisize, said: “Phillips-Medisize is excited to align with Molex on the transformation of the Little Rock facility, which will be a Center of Excellence for Connected Health and drug delivery devices and manufacture products that fit in today’s world of innovative devices. This facility will also allow us to accommodate large programs requiring extensive assembly and moulding operations, in clean room and other controlled environments, within a compressed timeframe. The facility will have a particular focus on mid- to high-volume diagnostics, medical device and drug delivery systems that integrate electronics and digital applications, and will provide us with the additional space needed to reach our growth objectives over the upcoming years.”